Trial · NCT03399604
Adverse events86
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 86
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cough | Respiratory, thoracic and mediastinal disorders | LIQ861 Add-On | 41 | 121 | 41 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Tyvaso Transition | 23 | 121 | 23 |
| other | Dysponea | Respiratory, thoracic and mediastinal disorders | LIQ861 Add-On | 10 | 121 | 10 |
| other | Dysponea | Respiratory, thoracic and mediastinal disorders | Tyvaso Transition | 13 | 121 | 13 |
| other | Throat irritation | Respiratory, thoracic and mediastinal disorders | LIQ861 Add-On | 14 | 121 | 14 |
| other | Throat irritation | Respiratory, thoracic and mediastinal disorders | Tyvaso Transition | 8 | 121 | 8 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | LIQ861 Add-On | 6 | 121 | 6 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Tyvaso Transition | 2 | 121 | 2 |
| other | Headache | Nervous system disorders | LIQ861 Add-On | 23 | 121 | 23 |
| other | Headache | Nervous system disorders | Tyvaso Transition | 18 | 121 | 18 |
| other | Dizziness | Nervous system disorders | LIQ861 Add-On | 13 | 121 | 13 |
| other | Dizziness | Nervous system disorders | Tyvaso Transition | 10 | 121 | 10 |
| other | Upper Respiratory Tract Infection | Infections and infestations | LIQ861 Add-On | 18 | 121 | 18 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Tyvaso Transition | 10 | 121 | 10 |
| other | Nasopharyngitis | Infections and infestations | LIQ861 Add-On | 6 | 121 | 6 |
| other | Nasopharyngitis | Infections and infestations | Tyvaso Transition | 6 | 121 | 6 |
| other | Urinary Tract Infection | Infections and infestations | LIQ861 Add-On | 6 | 121 | 6 |
| other | Urinary Tract Infection | Infections and infestations | Tyvaso Transition | 2 | 121 | 2 |
| other | Chest Discomfort | General disorders | LIQ861 Add-On | 7 | 121 | 7 |
| other | Chest Discomfort | General disorders | Tyvaso Transition | 11 | 121 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03399604/events